In two multicenter , double-masked , randomized , parallel-group studies ( study 1 : n = 173 [ idiopathic ] ; study 2 : n = 36 [ chemotherapy-induced ] ) , subjects received bimatoprost 0.03 % or vehicle applied once daily to the upper eyelid margins .